255 related articles for article (PubMed ID: 28956034)
1. Metabolomics reveal mitochondrial and fatty acid metabolism disorders that contribute to the development of DKD in T2DM patients.
Li L; Wang C; Yang H; Liu S; Lu Y; Fu P; Liu J
Mol Biosyst; 2017 Oct; 13(11):2392-2400. PubMed ID: 28956034
[TBL] [Abstract][Full Text] [Related]
2. Urine metabolomics reveals biomarkers and the underlying pathogenesis of diabetic kidney disease.
Luo M; Zhang Z; Lu Y; Feng W; Wu H; Fan L; Guan B; Dai Y; Tang D; Dong X; Yun C; Hocher B; Liu H; Li Q; Yin L
Int Urol Nephrol; 2023 Apr; 55(4):1001-1013. PubMed ID: 36255506
[TBL] [Abstract][Full Text] [Related]
3. Clinical metabolomics characteristics of diabetic kidney disease: A meta-analysis of 1875 cases with diabetic kidney disease and 4503 controls.
Yuan Y; Huang L; Yu L; Yan X; Chen S; Bi C; He J; Zhao Y; Yang L; Ning L; Jin H; Yang R; Li Y
Diabetes Metab Res Rev; 2024 Mar; 40(3):e3789. PubMed ID: 38501707
[TBL] [Abstract][Full Text] [Related]
4. The Mitochondria-Targeted Metabolic Tubular Injury in Diabetic Kidney Disease.
Jiang H; Shao X; Jia S; Qu L; Weng C; Shen X; Wang Y; Huang H; Wang Y; Wang C; Feng S; Wang M; Feng H; Geekiyanage S; Davidson AJ; Chen J
Cell Physiol Biochem; 2019; 52(2):156-171. PubMed ID: 30816665
[TBL] [Abstract][Full Text] [Related]
5. Impaired Amino Acid Metabolism and Its Correlation with Diabetic Kidney Disease Progression in Type 2 Diabetes Mellitus.
Zhu H; Bai M; Xie X; Wang J; Weng C; Dai H; Chen J; Han F; Lin W
Nutrients; 2022 Aug; 14(16):. PubMed ID: 36014850
[TBL] [Abstract][Full Text] [Related]
6. Development and internal validation of machine learning algorithms for end-stage renal disease risk prediction model of people with type 2 diabetes mellitus and diabetic kidney disease.
Zou Y; Zhao L; Zhang J; Wang Y; Wu Y; Ren H; Wang T; Zhang R; Wang J; Zhao Y; Qin C; Xu H; Li L; Chai Z; Cooper ME; Tong N; Liu F
Ren Fail; 2022 Dec; 44(1):562-570. PubMed ID: 35373711
[TBL] [Abstract][Full Text] [Related]
7. Integration of metabolomics and peptidomics reveals distinct molecular landscape of human diabetic kidney disease.
Jiang X; Liu X; Qu X; Zhu P; Wo F; Xu X; Jin J; He Q; Wu J
Theranostics; 2023; 13(10):3188-3203. PubMed ID: 37351171
[TBL] [Abstract][Full Text] [Related]
8. Metabolomic biomarkers in diabetic kidney diseases--A systematic review.
Zhang Y; Zhang S; Wang G
J Diabetes Complications; 2015; 29(8):1345-51. PubMed ID: 26253264
[TBL] [Abstract][Full Text] [Related]
9. Identification of Potential Serum Metabolic Biomarkers of Diabetic Kidney Disease: A Widely Targeted Metabolomics Study.
Zhang H; Zuo JJ; Dong SS; Lan Y; Wu CW; Mao GY; Zheng C
J Diabetes Res; 2020; 2020():3049098. PubMed ID: 32190695
[TBL] [Abstract][Full Text] [Related]
10. UPLC-MS-based urine nontargeted metabolic profiling identifies dysregulation of pantothenate and CoA biosynthesis pathway in diabetic kidney disease.
Ma T; Liu T; Xie P; Jiang S; Yi W; Dai P; Guo X
Life Sci; 2020 Oct; 258():118160. PubMed ID: 32730837
[TBL] [Abstract][Full Text] [Related]
11. Quantitative, Targeted Analysis of Gut Microbiota Derived Metabolites Provides Novel Biomarkers of Early Diabetic Kidney Disease in Type 2 Diabetes Mellitus Patients.
Balint L; Socaciu C; Socaciu AI; Vlad A; Gadalean F; Bob F; Milas O; Cretu OM; Suteanu-Simulescu A; Glavan M; Ienciu S; Mogos M; Jianu DC; Petrica L
Biomolecules; 2023 Jul; 13(7):. PubMed ID: 37509122
[TBL] [Abstract][Full Text] [Related]
12. Optimization of kidney dysfunction prediction in diabetic kidney disease using targeted metabolomics.
Ibarra-González I; Cruz-Bautista I; Bello-Chavolla OY; Vela-Amieva M; Pallares-Méndez R; Ruiz de Santiago Y Nevarez D; Salas-Tapia MF; Rosas-Flota X; González-Acevedo M; Palacios-Peñaloza A; Morales-Esponda M; Aguilar-Salinas CA; Del Bosque-Plata L
Acta Diabetol; 2018 Nov; 55(11):1151-1161. PubMed ID: 30173364
[TBL] [Abstract][Full Text] [Related]
13. Serum and Urinary Progranulin in Diabetic Kidney Disease.
Nicoletto BB; Krolikowski TC; Crispim D; Canani LH
PLoS One; 2016; 11(10):e0165177. PubMed ID: 27776152
[TBL] [Abstract][Full Text] [Related]
14. Metabolomic Signature of Diabetic Kidney Disease in Cerebrospinal Fluid and Plasma of Patients with Type 2 Diabetes Using Liquid Chromatography-Mass Spectrometry.
Lin HT; Cheng ML; Lo CJ; Lin G; Liu FC
Diagnostics (Basel); 2022 Oct; 12(11):. PubMed ID: 36359470
[TBL] [Abstract][Full Text] [Related]
15. Metabolic changes in urine and serum during progression of diabetic kidney disease in a mouse model.
Kim NH; Hyeon JS; Kim NH; Cho A; Lee G; Jang SY; Kim MK; Lee EY; Chung CH; Ha H; Hwang GS
Arch Biochem Biophys; 2018 May; 646():90-97. PubMed ID: 29621522
[TBL] [Abstract][Full Text] [Related]
16. Serum Human Epididymis Protein 4 is Associated with Renal Function and Diabetic Kidney Disease in Patients with Type 2 Diabetes Mellitus.
Zhang M; Zhao B; Xie J; Liang Y; Yang Z
Biomed Res Int; 2019; 2019():4831459. PubMed ID: 31815140
[TBL] [Abstract][Full Text] [Related]
17. Extracellular vesicles metabolic changes reveals plasma signature in stage-dependent diabetic kidney disease.
Pan Y; Yang H; Chen T; Jin J; Ruan L; Hu L; Chen L
Ren Fail; 2022 Dec; 44(1):1840-1849. PubMed ID: 36368309
[TBL] [Abstract][Full Text] [Related]
18. 1,5-Anhydroglucitol predicts CKD progression in macroalbuminuric diabetic kidney disease: results from non-targeted metabolomics.
Tavares G; Venturini G; Padilha K; Zatz R; Pereira AC; Thadhani RI; Rhee EP; Titan SMO
Metabolomics; 2018 Feb; 14(4):39. PubMed ID: 30830377
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA: an emerging player in diabetes and diabetic kidney disease.
Guo J; Liu Z; Gong R
Clin Sci (Lond); 2019 Jun; 133(12):1321-1339. PubMed ID: 31221822
[TBL] [Abstract][Full Text] [Related]
20. Serum lutein is a promising biomarker for type 2 diabetes mellitus and diabetic kidney disease in the elderly.
Pan F; Cui W; Gao L; Shi X; Yang H; Hu Y; Li M
J Clin Lab Anal; 2022 Apr; 36(4):e24350. PubMed ID: 35293029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
